World News Insights
1-3 Minute Gist

All Topics Article

Teva Deal Probe Gets Extension

Wall Street Journal Original article ›

Keywords:

LyrArc Article Gist
Teva Pharmaceutical's acquisition of generic drug maker Barr Pharmaceutical for $7.46 billion to strengthen its position in emerging markets and expand its product portfolio.

Pharmaceutical companies with Generics products are changing the marketplace.

07/26/2005

With growing demand for low cost affordable drugs the growth in sales of generics.

Grouped Articles

Indian Drug Maker Vies for Betapharm

Wall Street Journal 02/09/2006

Branded Drugs Settling More Generic Suits

Wall Street Journal 01/17/2006

Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain

Wall Street Journal 01/20/2006

As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future

Wall Street Journal 01/05/2006

Teva to Acquire Ivax, Another Maker of Generic Drugs

New York Times 07/26/2005

Heard on the Street

Wall Street Journal 07/26/2005


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us